Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo-Controlled Dose Escalation Study to Investigate the Safety and Pharmacokinetics After Single and Multiple Doses of SLV334 in Sequential Cohorts of Patients With Moderate and Severe Traumatic Brain Injury
Conditions
Interventions
SLV334
SLV334
+3 more
Locations
14
United States
Site Reference ID/Investigator# 45771
Baltimore, Maryland, United States
Site Reference ID/Investigator# 45775
Dayton, Ohio, United States
Site Reference ID/Investigator# 45770
Portland, Oregon, United States
Site Reference ID/Investigator# 45785
Pittsburgh, Pennsylvania, United States
Site Reference ID/Investigator# 45780
Pittsburgh, Pennsylvania, United States
Site Reference ID/Investigator# 45727
Haifa, Israel
Start Date
April 1, 2009
Primary Completion Date
August 1, 2010
Completion Date
August 1, 2010
Last Updated
September 21, 2011
NCT04521881
NCT07455136
NCT06725108
NCT06734026
NCT07357090
NCT06467708
Lead Sponsor
Abbott Products
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions